Primary hypothyroidism as a consequence of 131-I-metaiodobenzylguanidine treatment for children with neuroblastoma.

Picco, P; Garaventa, A; Claudiani, F; Gattorno, M; De Bernardi, B; Borrone, C

Picco, P; Garaventa, A; Claudiani, F; Gattorno, M; De Bernardi, B; Borrone, C.

Affiliation

Picco P; Second Division of Pediatrics, G. Gaslini Institute for Children, Genoa, Italy.

Cancer ; 76(9): 1662-4, 1995 Nov 01.

Article in En | MEDLINE | ID: mdl-8635072

Subject(s)

Antineoplastic Agents/adverse effects; Brain Neoplasms/radiotherapy; Hypothyroidism/etiology; Iodine Radioisotopes/adverse effects; Iodobenzenes/adverse effects; Neuroblastoma/radiotherapy; Radiotherapy/adverse effects; 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Follow-Up Studies; Humans; Hypothyroidism/blood; Prospective Studies; Thyroid Hormones/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy / Brain Neoplasms / Hypothyroidism / Iodine Radioisotopes / Iodobenzenes / Neuroblastoma / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Humans Language: En Journal: Cancer Year: 1995 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links